Found 0 matching trials
Plerixafor for Poorly Mobilized Lymphoma PHASE4 Autologous hematopoietic stem cell transplantation is one of the effective ...
Show More Location
Peking University Cancer Hospital & Institute
Learn More & Join Trial
Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia PHASE1 Second-line induction therapy with fludarabine, idarubicin, cytarabine,Gran...
Show More Location
Hospital Universitari Germans Trials i Pujol
Learn More & Join Trial
Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease Pilot and Feasibility Trial of Plerixafor for Hematopoietic Stem Cell (HSC) Mobilization in Patients With Sickle Cell Disease PHASE1 Sickle cell disease (SCD) is one of the most common genetic diseases in the...
Show More Location
Boston Childrens Hospital
Learn More & Join Trial
Gene Editing For Sickle Cell Disease PHASE1 This study is being done to test the safety of a new treatment called gene ...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients PHASE2 This study evaluates the safety of plerixafor and other outcomes that are p...
Show More Location
University of Cologne
Learn More & Join Trial
Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia PHASE1 This is a phase 1, dose escalation study of Plerixafor in combination with ...
Show More Learn More & Join Trial
To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers PHASE1 Pancreatic, ovarian and colorectal cancers are difficult to treat using che...
Show More Location
Addenbrookes Hospital
Learn More & Join Trial
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas PHASE1 This phase I/II trial studies the side effects and best dose of temozolomid...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal Impairment PHASE1 Eligible male and female subjects with renal impairment (aged 18-78 years) ...
Show More Location
Apex Research of Riverside
Learn More & Join Trial